The trajectory of Viagra, initially marketed by copyright, presents a complex case study for stakeholders considering the drug landscape . While its groundbreaking success and creation of vast in earnings , the exclusivity end has opened the floodgates for competing medications, substantially diminishing earnings opportunities. This change raises c